Park Ha CEO reports 381,000 Class B share stake

Park Ha Biological Technology Co., Ltd. director and CEO Zhang Xiaoqiu filed an initial Form 3 reporting her beneficial ownership in the company.

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. director and CEO Zhang Xiaoqiu filed an initial Form 3 reporting her beneficial ownership in the company. She is identified as a director, officer and ten percent owner.

The filing shows indirect ownership of 381,000 Class B Ordinary Shares, held through Xiaoqiu Holdings Limited, where she is the sole shareholder and director. A footnote states that these 381,000 Class B Ordinary Shares were acquired on October 11, 2022, and the Form 3 records this existing position rather than reporting a new market transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zhang Xiaoqiu

Role CEO

Type	Security	Shares	Price	Value
holding	Class B Ordinary Shares	--	--	--

Holdings After Transaction: Class B Ordinary Shares — 381,000 shares (Indirect, By Xiaoqiu Holding Ltd)

Footnotes (1)

1. F1. Directly held by Xiaoqiu Holdings Limited. Ms. Zhang is the sole shareholder and director of Xiaoqiu Holdings Limited. The Reporting Person acquired 381,000 Class B Ordinary Shares on October 11, 2022.

Key Figures

Indirect Class B share holding: 381,000 shares Acquisition date of reported shares: October 11, 2022 Holding entries in filing: 1 entry +1 more

4 metrics

Indirect Class B share holding 381,000 shares Class B Ordinary Shares held via Xiaoqiu Holdings Limited

Acquisition date of reported shares October 11, 2022 Date 381,000 Class B Ordinary Shares were acquired, per footnote

Holding entries in filing 1 entry Single holding line for Class B Ordinary Shares on Form 3

Reporting person roles CEO, director, ten percent owner Roles disclosed for Zhang Xiaoqiu in the issuer

Key Terms

Class B Ordinary Shares, indirect, ten percent owner, Form 3, +1 more

5 terms

Class B Ordinary Shares financial

"The Reporting Person acquired 381,000 Class B Ordinary Shares on October 11, 2022."

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

indirect financial

"total_shares_following_transaction ... ownership_type: indirect, ownership_code: I"

ten percent owner financial

""is_ten_percent_owner": 1"

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial Form 3 reporting her beneficial ownership in the company."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BYAH Form 3 filing show about Zhang Xiaoqiu’s holdings?

The Form 3 shows that CEO and director Zhang Xiaoqiu beneficially owns 381,000 Class B Ordinary Shares of Park Ha Biological Technology Co., Ltd., held indirectly through Xiaoqiu Holdings Limited, which records her existing stake as a ten percent owner.

How are the BYAH shares in this Form 3 held by Zhang Xiaoqiu?

The shares are held indirectly through Xiaoqiu Holdings Limited. The filing notes that the 381,000 Class B Ordinary Shares are directly held by Xiaoqiu Holdings Limited, where Ms. Zhang is the sole shareholder and director, making her the beneficial owner.

Did the BYAH Form 3 report a new share purchase by Zhang Xiaoqiu?

The Form 3 records an existing holding of 381,000 Class B Ordinary Shares, acquired on October 11, 2022, according to the footnote. It functions as an initial beneficial ownership report rather than disclosing a new buy or sell transaction.

What role does Zhang Xiaoqiu hold at Park Ha Biological Technology (BYAH)?

The filing identifies Ms. Zhang as CEO and director of Park Ha Biological Technology Co., Ltd., and also flags her as a ten percent owner. This combination of roles underscores her significant managerial position and substantial equity stake in the company.

What type of security is reported in the BYAH Form 3 for Zhang Xiaoqiu?

The Form 3 reports ownership of Class B Ordinary Shares of Park Ha Biological Technology Co., Ltd. It specifies that 381,000 Class B Ordinary Shares are beneficially owned through Xiaoqiu Holdings Limited, reflecting her indirect equity interest in the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 08:24 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhang Xiaoqiu

(Last) (First) (Middle)

PLOT C, NO.1 LIHU, BINHU DISTRICT

(Street)

WUXI 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2024

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B Ordinary Shares	381,000	I	By Xiaoqiu Holding Ltd(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Directly held by Xiaoqiu Holdings Limited. Ms. Zhang is the sole shareholder and director of Xiaoqiu Holdings Limited. The Reporting Person acquired 381,000 Class B Ordinary Shares on October 11, 2022.

	/s/ Zhang Xiaoqiu	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)